Login
← Go Back
Torrent Pharmaceuticals
TORNTPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: Samir Mehta Listing date: Oct. 24, 1994 · Employees: 13505 · Ahmedabad · http://www.torrentpharma.com
Stock Price vs Company Growth
1d
1.9%
1w
2.5%
1m
4.7%
3m
12.8%
6m
18.2%
1y
37.8%
5y
28.3%
10y
21.8%
all
28.0%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 4,988 1.9%
4,242
5,250
Company Overview
Sales
15,723 Cr
Growth: 21.2%
Profit after Tax
2,181 Cr
Growth: 0.8%
Large Cap
1,89,741 Cr
P/E: 79.9x
Industry P/E: 31.7x
Fundamentals
Sales (Cr) ₹ 15,723
Growth 21.2%
EBITDA 33.0%
P/S 12.1x
Dividend 0.9%
P/E 79.9x
Book Value ₹ 235
PEG Ratio 3.8x
ROE 24.6%
P/B 21.1x
Shareholding Pattern
Institutions
Mirae Asset Focused Fund
2.16 %
Qualified Institutional Buyer
1.63 %
Uti-Unit Linked Insurance Plan
1.28 %
Promoters
Torrent Investments Private Limited
71.25 %
Others
Ifpf
0.1 %
Increase    Decrease    No change
Company Profile Detailed
The Company is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations. Torrent Pharma is a leading player in the areas of Cardiovascular and Central Nervous Systems, having achieved significant presence in segments of Nephrology, Oncology, Pulmonology, Gynecology and Pediatric treatments. Business segmentsThe company operates in two key business segments - Branded Generics (BGx) and Generics (Gx).
Belongs to (55 Indices) view more
Investors (89)
marshall...
mirae.as...
ishares....
Followers (13)
nitin2
keerthi
deepak